Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jun;83(6):1357-1358.
doi: 10.1111/bcp.13276. Epub 2017 Apr 3.

Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'

Elisabet Størset  1   2 , Kristine Hole  3 , Karsten Midtvedt  1 , Stein Bergan  4   5 , Espen Molden  3   4 , Anders Åsberg  1   4
Affiliations
Comment

Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'

Elisabet Størset et al. Br J Clin Pharmacol. 2017 Jun.
No abstract available

Keywords: 4β-hydroxycholesterol; CYP3A; bodyweight; kidney transplantation; tacrolimus.

PubMed Disclaimer

Comment on

References

    1. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP, et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 2016; 44 (Database Issue): D1054–D1068. - PMC - PubMed
    1. Vanhove T, de Jonge H, de Loor H, Annaert P, Diczfalusy U, Kuypers DRJ. Comparative performance of oral midazolam clearance and plasma 4β‐hydroxycholesterol to explain interindividual variability in tacrolimus clearance. Br J Clin Pharmacol 2016; 82: 1539–1549. - PMC - PubMed
    1. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A. Bodyweight‐adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance. Br J Clin Pharmacol 2017; 83: 1350–1352. - PMC - PubMed
    1. Vanhove T, Annaert P, Kuypers DRJ. Reponse to: ‘Bodyweight‐adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance.’ Br J Clin Pharmacol 2017; 83: 1353–1356. - PMC - PubMed
    1. Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, et al. Improved tacrolimus target concentration achievement using computerized dosing in renal transplant recipients ‐ a prospective, randomized study. Transplantation 2015; 99: 2158–2166. - PMC - PubMed

LinkOut - more resources